Mohit Kumar Jolly

97PUBLICATIONS
269CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGeospatial information systems and geospatial data modellingSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Jul 28, 2026
Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma.

|Jul 01, 2026
Varying susceptibility of subpopulations along the epithelial-mesenchymal spectrum to undergo EMT.

|Jun 30, 2026
Distinct geometrical landscapes distinguish between modes of tristability in gene regulatory networks.

|Jun 26, 2026
TGF-β-producing tBregs are associated with poor survival rates in PTGS2-high cancers.

|May 25, 2026
Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancer.

|May 12, 2026
Ecological dynamics of pro-tumor and anti-tumor teams in the tumor microenvironment.

Pageof 17

Frequent Collaborators

9 joint publications

Kishore Hari

9 joint publications

Herbert Levine

5 joint publications

Jason Thomas George

4 joint publications

Paras Jain